FDA clears marketing of additional feature for NvisionVLE Imaging System: 4 points

FDA is allowing NinePoint Medical to market the Real-time Targeting feature for its flagship product, the NvisionVLE Imaging System.

Advertisement

Here are four points:

1. The NvisionVLE Imaging System uses proprietary Optical Coherence Tomography technology that allows physicians to perform a Volumetric Laser Endomicroscopy procedure.

2. The system enables gastroenterologists to evaluate tissue for potential disease that may not be visible with conventional medical imaging technologies.

3. The additional Real-time Targeting feature allows physicians to both locate as well as mark areas of interest.

4. The first procedures with the system and the new Real-time Targeting feature were performed at Beth Israel Deaconess Medical Center in Boston.

More articles on GI/endoscopy:
FMT helps reduce recurring episodes of C. Diff in children: 4 findings
GIQuIC registry hits 3M colonoscopy cases: 5 things to know
Certain body sugars help prevent UC & colon cancer — 5 points

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.